Literature DB >> 36091616

Recurrent nocturnal ST-T deviation and nonsustained ventricular tachycardias recorded with a smartwatch: A case report.

David Glöckner1, Tobias Zeus1, Malte Kelm1, Hisaki Makimoto1.   

Abstract

A 44-year-old male patient presented to our clinic with nocturnal palpitations. The smartwatch electrocardiogram (ECG) demonstrated ST-segment deviation and non-sustained ventricular tachycardias. The patient suffered from coronary one-vessel disease. The coronary angiography revealed de novo proximal left anterior descending stenosis and in-stent restenosis, which necessitated coronary stenting. However, the recurrent palpitations reappeared 2 weeks later. The smartwatch ECGs again demonstrated ST-segment deviation and wide QRS tachycardia, reassessments with coronary angiography and magnetic resonance imaging revealed no relevant ischemia. The patient was diagnosed with vasospastic angina. His symptoms disappeared after percutaneous administration of nitrates.This case highlights the utility of smartwatch ECGs to support clinical diagnosis, decisions, and follow-up in the case of ischemic attacks. Learning objective: This case report highlights the importance of an adequate anamnesis and the meaningful use of wearable devices. The smartwatch enables the patient to record electrocardiograms (ECGs) easily and immediately during symptoms. That is one of the major advantages of this new technology, because we can even detect events that are too subtle to be detected in the normal 24-h Holter ECG. This case highlights the utility of smartwatch ECGs to support clinical diagnosis and decisions by establishing a valid symptom-ECG correlation.
© 2022 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved. All rights reserved.

Entities:  

Keywords:  Nocturnal palpitations; Non-sustained ventricular tachycardias; Smartwatch; Vasospastic angina

Year:  2022        PMID: 36091616      PMCID: PMC9449772          DOI: 10.1016/j.jccase.2022.04.006

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  First case reported of a Prinzmetal vasospastic angina diagnosed with the help of a smartwatch.

Authors:  Antoine Delinière; Benoît Desgraz; Claudia Herrera-Siklody; Patrizio Pascale; Olivier Muller; Etienne Pruvot
Journal:  Europace       Date:  2021-06-07       Impact factor: 5.214

2.  2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.

Authors:  Juhani Knuuti; William Wijns; Antti Saraste; Davide Capodanno; Emanuele Barbato; Christian Funck-Brentano; Eva Prescott; Robert F Storey; Christi Deaton; Thomas Cuisset; Stefan Agewall; Kenneth Dickstein; Thor Edvardsen; Javier Escaned; Bernard J Gersh; Pavel Svitil; Martine Gilard; David Hasdai; Robert Hatala; Felix Mahfoud; Josep Masip; Claudio Muneretto; Marco Valgimigli; Stephan Achenbach; Jeroen J Bax
Journal:  Eur Heart J       Date:  2020-01-14       Impact factor: 29.983

3.  Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina.

Authors:  Hongtao Sun; Masahiro Mohri; Hiroaki Shimokawa; Makoto Usui; Lemmy Urakami; Akira Takeshita
Journal:  J Am Coll Cardiol       Date:  2002-03-06       Impact factor: 24.094

Review 4.  The clinical significance of continuous ECG (ambulatory ECG or Holter) monitoring of the ST-segment to evaluate ischemia: a review.

Authors:  Neil J Wimmer; Benjamin M Scirica; Peter H Stone
Journal:  Prog Cardiovasc Dis       Date:  2013-08-16       Impact factor: 8.194

5.  Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia.

Authors:  Yuya Matsue; Makoto Suzuki; Mitsuhiro Nishizaki; Rintaro Hojo; Yuji Hashimoto; Harumizu Sakurada
Journal:  J Am Coll Cardiol       Date:  2012-07-25       Impact factor: 24.094

6.  Smart watch recording of ventricular tachycardia: Case study.

Authors:  Maxime Ringwald; Alexandre Crich; Nicolas Beysard
Journal:  Am J Emerg Med       Date:  2019-11-18       Impact factor: 2.469

7.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.

Authors:  Gerhard Hindricks; Tatjana Potpara; Nikolaos Dagres; Elena Arbelo; Jeroen J Bax; Carina Blomström-Lundqvist; Giuseppe Boriani; Manuel Castella; Gheorghe-Andrei Dan; Polychronis E Dilaveris; Laurent Fauchier; Gerasimos Filippatos; Jonathan M Kalman; Mark La Meir; Deirdre A Lane; Jean-Pierre Lebeau; Maddalena Lettino; Gregory Y H Lip; Fausto J Pinto; G Neil Thomas; Marco Valgimigli; Isabelle C Van Gelder; Bart P Van Putte; Caroline L Watkins
Journal:  Eur Heart J       Date:  2021-02-01       Impact factor: 29.983

Review 8.  Smart wearable devices in cardiovascular care: where we are and how to move forward.

Authors:  Karim Bayoumy; Mohammed Gaber; Abdallah Elshafeey; Omar Mhaimeed; Elizabeth H Dineen; Francoise A Marvel; Seth S Martin; Evan D Muse; Mintu P Turakhia; Khaldoun G Tarakji; Mohamed B Elshazly
Journal:  Nat Rev Cardiol       Date:  2021-03-04       Impact factor: 32.419

9.  Beta blockers versus calcium channel blockers for provocation of vasospastic angina after drug-eluting stent implantation: a multicentre prospective randomised trial.

Authors:  Mitsuaki Sawano; Toshiomi Katsuki; Shun Kohsaka; Takeshi Kitai; Koichi Tamita; Kotaro Obunai; Yukinori Ikegami; Takafumi Yamane; Ikuko Ueda; Ayaka Endo; Yuichiro Maekawa; Akio Kawamura; Keiichi Fukuda
Journal:  Open Heart       Date:  2020-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.